{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:10:12Z","timestamp":1790755812414,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003598"],"award-info":[{"award-number":["82003598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173668"],"award-info":[{"award-number":["82173668"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejmech.2023.115664","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T11:38:36Z","timestamp":1689680316000},"page":"115664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Discovery of Ibrutinib-based BTK PROTACs with in vivo anti-inflammatory efficacy by inhibiting NF-\u03baB activation"],"prefix":"10.1016","volume":"259","author":[{"given":"Junli","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengzhu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingna","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5668-6572","authenticated-orcid":false,"given":"Jianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2023.115664_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1021\/acs.jproteome.6b00599","article-title":"Inflammasome-derived exosomes activate NF-\u03baB signaling in macrophages","volume":"16","author":"Zhang","year":"2017","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115664_bib2","first-page":"1","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"8","key":"10.1016\/j.ejmech.2023.115664_bib3","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/00003246-199608000-00004","article-title":"Nuclear factor-\u03baB is activated in alveolar macrophages from patients with acute respiratory distress syndrome","volume":"24","author":"Schwartz","year":"1996","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115664_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaut.2008.04.012","article-title":"Immune deficiency or hyperactivity-Nf-\u03bab illuminates autoimmunity","volume":"31","author":"Pai","year":"2008","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ejmech.2023.115664_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1982570","article-title":"STAT3 activation in combination with NF-KappaB inhibition induces tolerogenic dendritic cells with high therapeutic potential to attenuate collagen-induced arthritis","volume":"2019","author":"Prado","year":"2019","journal-title":"Journal of Immunology Research"},{"issue":"14","key":"10.1016\/j.ejmech.2023.115664_bib6","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1021\/acs.jmedchem.7b01557","article-title":"Discovery of novel small-molecule inhibitors of NF-kappa B signaling with antiinflammatory and anticancer properties","volume":"61","author":"Zhang","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115664_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1084\/jem.184.1.31","article-title":"A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2","volume":"184","author":"Takata","year":"1996","journal-title":"J. Exp. Med."},{"issue":"23","key":"10.1016\/j.ejmech.2023.115664_bib8","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1182\/blood-2011-01-328484","article-title":"Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765","volume":"117","author":"Herman","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ejmech.2023.115664_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/13543784.2017.1349097","article-title":"Bruton's tyrosine kinase inhibitors in B-cell lymphoma: current experience and future perspectives","volume":"26","author":"Seiler","year":"2017","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"29","key":"10.1016\/j.ejmech.2023.115664_bib10","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"17","key":"10.1016\/j.ejmech.2023.115664_bib11","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1021\/acs.jmedchem.9b00687","article-title":"Discovery of Zanubrutinib (BGB-3111), a novel, potent, and selective covalent inhibitor of bruton's tyrosine kinase","volume":"62","author":"Guo","year":"2019","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115664_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40265-021-01482-5","article-title":"Orelabrutinib: first approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ejmech.2023.115664_bib13","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2007-07-102343","article-title":"Bmx tyrosine kinase regulates TLR4-induced IL-6 production in human macrophages independently of p38 MAPK and NF kappa B activity","volume":"111","author":"Palmer","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ejmech.2023.115664_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-019-05379-w","article-title":"The protective effect of Geniposide on diabetic cognitive impairment through BTK\/TLR4\/NF-kappa B pathway","volume":"237","author":"Liu","year":"2020","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.ejmech.2023.115664_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.15252\/emmm.201404556","article-title":"Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus","volume":"7","author":"Herbst","year":"2015","journal-title":"EMBO Mol. Med."},{"issue":"51","key":"10.1016\/j.ejmech.2023.115664_bib19","doi-asserted-by":"crossref","first-page":"36953","DOI":"10.1074\/jbc.M707682200","article-title":"Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase","volume":"282","author":"Doyle","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115664_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.intimp.2018.03.019","article-title":"Inhibitor of Bruton's tyrosine kinases, PCI-32765, decreases pro-inflammatory mediators' production in high glucose-induced macrophages","volume":"58","author":"Fan","year":"2018","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115664_bib21","article-title":"Btk regulates macrophage polarization in response to lipopolysaccharide","volume":"9","author":"J","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ejmech.2023.115664_bib22","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1111\/bph.15778","article-title":"Bruton's TK regulates myeloid cell recruitment during acute inflammation","volume":"179","author":"Purvis","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115664_bib23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/jm500305p","article-title":"Structure-based drug design of RN486, a potent and selective Bruton's tyrosine kinase (BTK) inhibitor, for the treatment of rheumatoid arthritis","volume":"58","author":"Lou","year":"2015","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115664_bib24","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1021\/acs.jmedchem.1c00926","article-title":"Discovery and preclinical characterization of BIIB091, a reversible, selective BTK inhibitor for the treatment of multiple sclerosis","volume":"65","author":"Hopkins","year":"2021","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2023.115664_bib25","doi-asserted-by":"crossref","first-page":"7643","DOI":"10.1021\/acs.jmedchem.9b00794","article-title":"Discovery of evobrutinib: an oral, potent, and highly selective, covalent bruton's tyrosine kinase (BTK) inhibitor for the treatment of immunological diseases","volume":"62","author":"Caldwell","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115664_bib26","article-title":"Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma","author":"David","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2023.115664_bib27","article-title":"Battling btk mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations","author":"Adam","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"11","key":"10.1016\/j.ejmech.2023.115664_bib28","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/bloodadvances.2019001319","article-title":"Novel mouse model resistant to irreversible BTK inhibitors: a tool identifying new therapeutic targets and side effects","volume":"4","author":"Estupi\u00f1\u00e1n","year":"2020","journal-title":"Blood Adv."},{"issue":"22","key":"10.1016\/j.ejmech.2023.115664_bib29","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1016\/j.bmcl.2008.07.114","article-title":"Targeted intracellular protein degradation induced by a small molecule: en route to chemical proteomics","volume":"18","author":"Schneekloth","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"26","key":"10.1016\/j.ejmech.2023.115664_bib30","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1021\/acs.biochem.8b00391","article-title":"Targeting the C481S ibrutinib-resistance mutation in bruton's tyrosine kinase using PROTAC-mediated degradation","volume":"57","author":"Buhimschi","year":"2018","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.ejmech.2023.115664_bib31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41422-018-0055-1","article-title":"PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies","volume":"28","author":"Sun","year":"2018","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115664_bib32","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1038\/s41467-020-17997-6","article-title":"Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry","volume":"11","author":"Guo","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.115664_bib33","article-title":"Novel CRBN-recruiting proteolysis-targeting Chimeras as degraders of stimulator of interferon genes with in vivo anti-inflammatory efficacy","author":"Liu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115664_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105447","article-title":"Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity","volume":"117","author":"Li","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115664_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112377","article-title":"Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1","volume":"199","author":"Cheng","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"25","key":"10.1016\/j.ejmech.2023.115664_bib37","doi-asserted-by":"crossref","first-page":"23496","DOI":"10.1074\/jbc.C500053200","article-title":"Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide","volume":"280","author":"Doyle","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115664_bib38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.shk.0000155350.95435.28","article-title":"Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome","volume":"23","author":"Volman","year":"2005","journal-title":"Shock"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342300630X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342300630X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:56:05Z","timestamp":1759330565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342300630X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"alternative-id":["S022352342300630X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115664","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of Ibrutinib-based BTK PROTACs with in vivo anti-inflammatory efficacy by inhibiting NF-\u03baB activation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115664"}}